Terminal
Spotlight
Cashu Research

← Back to Terminal

Stocks
Healthcare
NASDAQ
EOLS

Market Cap: $478.83M

EI

Evolus, Inc.

EOLS

NASDAQ (NASDAQ Global Market)USD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Advertisers Brokers Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Cashu Research is part of Cashu Technology Pty Ltd, which is an authorised representative (AR # 001318029) of Adviser Solutions Group Pty Ltd (ABN 88 601 875 521) (AFSL 485946) (ASG).

This material is general advice only and is not an offer for the purchase or sale of any financial product or service. The material is not intended to provide you with personal financial or tax advice and does not take into account your personal objectives, financial situation or needs. Although we believe that the material is correct, no warranty of accuracy, reliability or completeness is given, except for liability under statute which cannot be excluded. Please note that past performance may not be indicative of future performance and that no guarantee of performance, the return of capital or a particular rate of return is given by Cashu Technologies Pty Ltd, any of their related body corporates or any other person. To the maximum extent possible, Cashu Technologies Pty Ltd, their related body corporates or any other person do not accept any liability for any statement in this material.

News

Evolus Expands Market Presence and Enhances Customer Experience Ahead of Earnings Report

### Evolus Focuses on Market Expansion and Customer Experience Evolus, a company specializing in aesthetic injectables, is actively enhancing its market presence and customer experience. As it prepare…

Cashu Finance·12 months ago

Evolus Launches Jeuveau: New Neurotoxin Approval Enhances Aesthetic Product Portfolio

Evolus Expands Product Portfolio with New Neurotoxin Approval Evolus, a company specializing in aesthetic injectables, makes a significant stride in its product offerings with the recent approval of i…

Cashu Finance·1 year ago

Evolus Expands Workforce and Product Line to Capture Aesthetic Market Growth

Evolus Expands Workforce and Product Portfolio Amid Growth in Aesthetic Market Evolus, Inc., a rising contender in the performance beauty industry, focuses on enhancing its workforce and bolstering it…

Cashu Finance·over 1 year ago

Evolus Expands Workforce and Product Line in Aesthetic Market for Future Growth

Evolus Expands Team and Product Offerings in Aesthetic Market Evolus, Inc., a performance beauty company known for its focus on aesthetics, makes significant strides in enhancing its workforce and pro…

Cashu Finance·almost 2 years ago

Evolus Boosts Workforce with Strategic Stock Options to Enhance Growth and Innovation

Evolus Expands Workforce with Strategic Stock Option Grants Evolus, Inc., a performance beauty company known for its aesthetic products, recently implements a strategic initiative to enhance its workf…

Cashu Finance·almost 2 years ago

Evolus Navigates Competitive ENT Market Amidst OptiNose Challenges and Investor Interest

Evolus Faces Increased Competition in the ENT Market Amid Investment Moves Evolus, a company specializing in aesthetic treatments, finds itself navigating a competitive landscape as interest in the ea…

Cashu Finance·almost 2 years ago

Evolus Strengthens Aesthetic Neurotoxin Market Position with Jeuveau® and New Product Launches

Evolus Reinforces Its Position in the Aesthetic Neurotoxin Market Evolus, Inc., a Newport Beach-based performance beauty company, is poised to enhance its presence in the aesthetic neurotoxin market.…

Cashu Finance·almost 2 years ago

Evolus Secures EU Certification to Launch Estyme® Injectable Hyaluronic Acid Gels in Europe

Evolus Expands Market Reach with New Injectable Hyaluronic Acid Gels Evolus, Inc., a performance beauty company renowned for its focus on aesthetic consumer brands, marks a significant milestone in it…

Cashu Finance·almost 2 years ago

Evolus Enters European Aesthetic Market with CE Certification for Estyme® Dermal Filler

Evolus Marks Entry into European Aesthetic Market with CE Mark Certification for Estyme® Evolus, Inc., a prominent player in the performance beauty sector, achieves a significant milestone by securing…

Cashu Finance·almost 2 years ago

Evolus Expands with Estyme®: EU Certification for Injectable Hyaluronic Acid Gels

Evolus Expands Market Reach with New Injectable Hyaluronic Acid Gels Evolus, Inc., a performance beauty company recognized for its focus on aesthetic consumer brands, recently achieves a major milesto…

Cashu Finance·almost 2 years ago